Pharmafile Logo

The CM Group rebrands to OPEN Health

Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding and will now be known as OPEN Health.

London, UK – April 25, 2023 – Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding and will now be known as OPEN Health. The CM Group brands included decile.ten, the PX Group, and Scientific Commercialization.

Since its inception in 2011, OPEN Health has expanded its expertise and global reach through mergers, acquisitions, and organic growth to be at the forefront of the healthcare industry. It has brought together global experts from consulting, HEOR, market access, medical communications, and creative omnichannel communications to provide unrivaled global healthcare specialist expertise with the purpose of improving patient outcomes and wellbeing.

“We are proud to offer our clients a wide and unique range of global capabilities and geographies across an integrated service model,” said Rob Barker, CEO of OPEN Health. “We are delighted to integrate The CM Group into our global team of over 1,300 experts who partner with 38 of the top 40 biopharmaceutical and medical device companies, serving clients from Medical Affairs, HEOR, market access, and commercial teams.”

President of the recently acquired agency, Cherie Myatt, added, “For over 20 years, The CM Group has provided exceptional service to clients, due in large part to our passionate and dedicated team. We will continue to deliver on our promise as we integrate and expand our offerings with an equally dynamic team of experts. The integration journey with OPEN Health has been an exciting and rewarding one, and we are pleased to be able to now offer a wider range of expertise to our clients.”

About OPEN Health

OPEN Health unites deep scientific knowledge with wide‑ranging specialist expertise to unlock possibilities that improve health outcomes and patient wellbeing.

We are a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market accessscientific communications, and creative omnichannel communications.

For more information, please visit www.openhealthgroup.com.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office

OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, announced a new team of experts will lead its HEOR & Market Access Scientific Office.

OPEN Health Appoints Richard Jones as President for Evidence & Access

OPEN Health is pleased to announce the appointment of Richard Jones as President for Evidence & Access.

Drive, Discover, Dive_OPEN Health

Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.

Novel Oncology Therapies Require Innovative Methods in Oncology Modeling

Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.

The CM Group rebrands to OPEN Health

Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding...

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.

Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access

OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.

OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital

OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical...

How digital health is changing the relationship between patients and health providers | OPEN Health

The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes